粒径
分散性
Zeta电位
肺表面活性物质
硬脂酸
析因实验
色谱法
固体脂质纳米粒
化学
超声
溶解度
油酸
生物利用度
化学工程
材料科学
纳米颗粒
有机化学
纳米技术
生物化学
数学
工程类
生物信息学
统计
物理化学
生物
作者
Shailendra Bhatt,Ruchi Kamboj,JAI BHARTI SHARMA,Manish Kumar,Vipin Saini,Shailendra Mandge .
标识
DOI:10.4274/tjps.galenos.2019.32656
摘要
OBJECTIVES: This work aims to develop nanostructured lipid carriers (NLCs) to improve the oral bioavailability of febuxostat (FEB). MATERIALS AND METHODS: High shear homogenization, a well-known technique, followed by bath sonication with slight modifications was used to prepare FEB-loaded NLCs using oleic acid as liquid lipid and stearic acid as solid lipid. A total of 3² full factorial design was utilized to examine the effect of 2 independent variables, namely, X1 (liquid to solid lipid ratio) and X2 (surfactant concentration) on the Y1 (particle size) and Y2 (% entrapment efficiency) of the drug. The prepared NLCs were evaluated for particle size, polydispersity index, zeta potential, and (%) entrapment efficiency. RESULTS: The drug's highest solubility was found in the stearic (solid lipid) and oleic acid (liquid lipid), which were further chosen for NLC preparation. Result of the present study showed an increase in entrapment efficiency and a decrease in particle size with the increase in liquid lipid to solid lipid ratio. With increased surfactant concentration, a small particle size is observed. The optimized formulation's particle size and (%) entrapment efficiency was found to be 99 nm and 80%, respectively. The formulations' zeta potential and polydispersity index were found within the range. Compared to plain drug suspension, the optimized formulation showed higher drug release, which may be due to the presence of the higher amount of liquid lipid. The particles shown in the transmission electron microscopy were round in shape and have smooth surface. Stability studies showed that the NLC formulation can be stored for a longer time period under room condition. CONCLUSION: FEB-loaded NLC were successfully prepared using full 3² factorial design, and can be further used for oral delivery of FEB for gout treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI